Advertisement

DNA Vaccines pp 169-172 | Cite as

Immunostimulatory CpG Motifs and DNA Vaccines

  • Risini Weeratna
  • Arthur M. Krieg
  • Heather L. Davis
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 29)

Abstract

Bacterial DNA, but not vertebrate DNA, causes direct stimulation of several components of the vertebrate immune system. This activation is due to the presence of unmethylated CpG dinucleotides (1), which are present at the expected frequency in bacterial DNA, but are underrepresented (“CpG suppression”) and methylated in vertebrate DNA (2). The immunostimulatory effects include direct induction of B cell proliferation and immunoglobulin (Ig) secretion (1), as well as activation of monocytes, macrophages, and dendritic cells to upregulate their expression of costimulatory molecules, which drive immune responses, and secreting a variety of cytokines, including high levels of IL-12 (3,4). These cytokines then, in turn, stimulate natural killer (NK) cells to secrete IFN-γ and to have increased lytic activity (5). Overall, CpG DNA induces a Th1 like pattern of cytokine production dominated by IL-12 and IFN-γ, with little secretion of Th2 cytokines (4,5). These effects can also be obtained with synthetic oligonucleotides (ODN) (6,7) or plasmid DNA vectors (8) containing CpG immunostimulatory motifs. From a teleological view, it appears likely that the rapid immune activation in response to CpG DNA may have evolved as one component of the innate immune defense mechanisms that recognize structural patterns specific to microbial molecules.

Keywords

Cell Antigen Receptor Phosphodiester Backbone Vertebrate Immune System Teleological View Phosphorothioate Backbone 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Krieg, A. M., Yi, A., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., et al. (1995) CpG motifs in bacterial DNA trigger direct B cell activation. Nature 374, 543–549.CrossRefGoogle Scholar
  2. 2.
    Pisetsky, D. S. (1996) Immune activation by bacterial DNA: A new genetic code. Immunity 5, 303–310.PubMedCrossRefGoogle Scholar
  3. 3.
    Klinman, D., Yi, A., Beaucage, S. L., Conover, J., and Krieg, A. M. (1996) CpG motifs expressed by bacterial DNA rapidly induce lymphocytes to secrete IL-6, IL-12 and IFN. Proc. Natl. Acad. Sci. USA 93, 2879–2883.PubMedCrossRefGoogle Scholar
  4. 4.
    Halpern, M. D., Kurlander, R. J., and Pisetsky, D. S. (1996) Bacteria DNA induces murine interferon-g production by stimulation of interleukin-12 and tumor necrosis factor-cell. Immunol. 167, 72.Google Scholar
  5. 5.
    Cowdery, J. S., Chase, J. H., and Krieg, A. M. (1996) Bacterial DNA induces in vivo interferon-γ production by NK cells and increases sensitivity to endotoxin. J. Immunol. 156, 4570.PubMedGoogle Scholar
  6. 6.
    Davis, H. L., Weeratna, R., Waldschmid, T. J., Tygrett, L., Schorr, J., and Krieg, A.M. (1998) CpG DNA is a potent enhancer in mice immunized with recombinant hepatitis B surface antigen. J. Immunol. 160, 870–876.PubMedGoogle Scholar
  7. 7.
    Roman, M., Martinorozco, E., Goodman, S., Nguyen, M. D., Sato, Y., Ronaghy, A., Kornbluth, R. S., Richman, D. D., Carson, D. A., and Raz, E. (1997) Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants, Nature Med. 3, 849–854.PubMedCrossRefGoogle Scholar
  8. 8.
    Sato, Y., Roman, M., Tighe, H., Lee, D., Corr, M., Nguyen, M., Silverman, G. J., Lotz, M., Carson, D. A., and Raz, E. (1996) Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273, 352–354.PubMedCrossRefGoogle Scholar
  9. 9.
    Krieg, A. M. (1999) CpG DNA: a novel immunomodulator. Trends Microbiol. 7, 64,65.PubMedCrossRefGoogle Scholar
  10. 10.
    Zhao, Q., Matson S., Herrera C. J., Fisher E., Yu H., and Krieg A. M. (1993) Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Develop. 3, 53–66.Google Scholar
  11. 11.
    Guidotti, L. G., Guilhot, S., and Chisari, F. V. (1994) Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and-independent pathways. J. Virol. 68, 1265–1270.PubMedGoogle Scholar
  12. 12.
    Romero, R. and Lavine, J. E. (1996) Cytokine inhibition of the Hepatitis B virus core promoter. J. Hepatol. 23, 17–23.CrossRefGoogle Scholar
  13. 13.
    Harms, J. S. and Splitter, G. A. (1995) Interferon-gamma inhibits transgene expression driven by SV40 or CMV promoters but augments expression driven by the mammalian MHC1 promoter. Hum. Gene. Ther. 6, 1291–1297.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2000

Authors and Affiliations

  • Risini Weeratna
    • 1
  • Arthur M. Krieg
    • 1
  • Heather L. Davis
    • 2
  1. 1.Loeb Research InstituteOttawa Civic HospitalOttawaCanada
  2. 2.Ottawa Civic HospitalOttawaCanada

Personalised recommendations